While these data are in line with a study showing anti-tumor activity of anti-CD96 mAbs against a human clear cell carcinoma cell line xenotransplanted in SCID beige mice [71], they are opposed by a recent report indicating that CD96 crosslinking activates mouse and human CD8+ T cells [43]. Here, CD8A is linked to neoplasm.